spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

 

For further information please contact:

Advertising
Jonathan Smith

Editorial
Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


View the digital version of EPC




 

epc
 
 
Featured in this issue
Therapeutic Innovation
Ageing Populations

Beyond a Single Pill


Capsugel’s Sven Stegemann describes why a ‘one-size-fits-all’ approach to drug design is no longer sufficient in the treatment of diseases of ageing. Various patient-centric products should be explored – and are sometimes essential to adherence in elderly populations.
Labs & Logistics
Laboratory Relocation

The Right Move


Potential research disruption, damage to samples and heavy costs can strike fear into any company considering a laboratory move. John Best at Andrew Porter Ltd tells us how to make a success of any relocation.
  Research and Development
Diseases of Ageing

Finding the Trigger


Ciriaco Maraschiello at Harlan Contract Research Services believes that, in order to produce more efficacious treatments for age-related conditions, the triggering mechanisms of these diseases need to be fully understood.

spacer
Edited by
Dr Graham Hughes,
Consultant in
Pharmaceutical
Development
Published quarterly in
March, June,
September and December
Banner of PCI.EPC on Samedan
Banner of Samedan app.EPC on Samedan
Banner of Woodley.EPC on Samedan
 
Industry Events

4th Annual Drug Delivery and Formulation Asia Summit

12-14 November 2014, Wyndham Bund East Shanghai Hotel, Shanghai, China

Since 2011 when DDF Asia Summit was launched, with you kindly supports we have went through 3 years. We bring it up as a child with the expectation that more and more people will like it. DDF Asia summit is devoted to adding value to our clients and promoting industry progress.
More info >>

 
News and Press Releases

Pre-Filled Syringes 2015: Latest updates from Novartis, Janssen, Novo Nordisk, Boehringer Ingelheim…

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. This field is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. The issue of pre-filled syringe safety has received increased attention as of late, with both integrated pre-fillable safety syringes and safety solutions designed to accommodate existing pre-fillable syringes advancing commercially.
More info >>

air transport logo

 

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement